Mclaughlin John
Sonoma Pharmaceuticals, Inc. · Director
Mclaughlin John is listed in filings as Director at Sonoma Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 2, 2026, including 2 public disclosures. Recent filings connect the profile to Sonoma Pharmaceuticals, Inc. (SNOA). The current snapshot covers public activity from Jan 3, 2025 to Jan 2, 2026. Reported amounts are shown as $36.8K to $20.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||